Trials / Completed
CompletedNCT02571998
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Multicenter Study to Evaluate the Safety and Efficacy of CLS001 Topical Gel Versus Vehicle Applied Once Daily for 12 Weeks to Female Subjects With Moderate to Severe Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- Female
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and efficacy of Omiganan (CLS001) topical gel compared to vehicle topical gel applied once daily for 12 weeks in female subjects with moderate to severe inflammatory acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omiganan (CLS001) Topical Gel | |
| DRUG | Vehicle Topical Gel |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2015-10-08
- Last updated
- 2017-03-27
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02571998. Inclusion in this directory is not an endorsement.